Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma. 2022

Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
1Department of Neurosurgery, University Hospital of Münster.

OBJECTIVE Administration of 5-aminolevulinic acid (5-ALA) does not regularly elicit fluorescence in low-grade glioma (LGG) at currently established doses and timing of administration. One explanation may be differences in blood-brain barrier (BBB) integrity compared to high-grade glioma. The authors hypothesized that for a BBB semipermeable to 5-ALA there might be a relationship between plasma 5-ALA concentration and its movement into the brain. A higher dose would elicit more 5-ALA conversion into protoporphyrin IX (PPIX). The authors present a case series of patients harboring LGG who received higher doses of 5-ALA. METHODS Patients undergoing surgery for indeterminate glioma later diagnosed as LGG were included in this study. 5-ALA was administered at a standard dose of 20 mg/kg body weight (bw) 4 hours prior to induction of anesthesia. A subgroup of patients received a higher dose of 40 mg/kg bw. Fluorescence was evaluated visually and PPIX concentration (cPPIX) was determined ex vivo by hyperspectral measurements in freshly extracted tissue. All adverse events were recorded. RESULTS A total of 23 patients harboring diffuse low-grade astrocytomas (n = 19) and oligodendrogliomas (n = 4) were analyzed. Thirteen patients received 20 mg/kg bw, and 10 patients received 40 mg/kg bw of 5-ALA. In the 20 mg/kg group, 30.8% (4 of 13) of tumors harbored areas of visible fluorescence, compared to 60% of cases (n = 6 of 10) with 40 mg/kg bw. The threshold to visibility was 1 μg/ml in both groups. Measured over all biopsies, the mean cPPIX was significantly higher in the double-dose group (1.8 vs 0.45 μg/ml; p < 0.001). In non-visibly fluorescent tissue the mean cPPIX was 0.146 μg/ml in the 20 mg/kg and 0.347 μg/ml in the 40 mg/kg group, indicating an increase of 138% (p < 0.001). CONCLUSIONS These observations demonstrate different regions with different levels of PPIX accumulation in LGG. With higher 5-ALA doses cPPIX increases, leading to more regions surpassing the visibility threshold of 1 μg/ml. These observations can be explained by the fact that the BBB in LGG is semipermeable to 5-ALA. Higher 5-ALA doses result in more PPIX conversion, an observation with implications for future dosing in LGG.

UI MeSH Term Description Entries

Related Publications

Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
July 2012, Journal of neuro-oncology,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
June 2012, Oncology reports,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
September 2015, Journal of neurosurgery,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
January 1997, Journal of the Society for Gynecologic Investigation,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
January 2009, Pathobiology : journal of immunopathology, molecular and cellular biology,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
January 1997, Cancer letters,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
January 2012, PloS one,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
August 2001, Journal of photochemistry and photobiology. B, Biology,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
January 2004, Folia histochemica et cytobiologica,
Eric Suero Molina, and David Black, and Sadahiro Kaneko, and Michael Müther, and Walter Stummer
July 2018, Anticancer research,
Copied contents to your clipboard!